CIBC World Markets’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

CIBC World Markets’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-100,000	Closed	-$1.57M	–	819
2024 Q1	$1.57M	Buy	+100,000	New	+$1.54M	0.01%	568
2023 Q4	–	Sell	-300,000	Closed	-$3.82M	–	778
2023 Q3	$3.82M	Hold	300,000	–	–	0.04%	275
2023 Q2	$4.22M	Buy	+300,000	New	+$4.29M	0.03%	331

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

CIBC World Markets's DCPH Position: Q2 2024 in Review

CIBC World Markets sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 100,000 shares — an estimated $1.57M sold.

CIBC World Markets first reported a position in DCPH in Q2 2023 and held it in 3 quarters. The position peaked at $4.22M in Q2 2023. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

CIBC World Markets reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
CIBC World Markets sold 100,000 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $1.57M.
CIBC World Markets first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
CIBC World Markets's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $4.22M in Q2 2023.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on CIBC World Markets's 13F filing for Q2 2024, filed 12 Aug 2024.